Thyroxine supplementation in preterm infants: Critical analysis

Current Opinion in Pediatrics

Volumn 14, Issue 4, 2002, Pages 447-452

  Oden, Jon ^a   Freemark, Michael ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIOTHYRONINE; THYROTROPIN; THYROXINE;

CHILD GROWTH; COGNITION; DRUG EFFECT; HORMONE METABOLISM; HUMAN; HYPOTHALAMUS HYPOPHYSIS SYSTEM; HYPOTHYROIDISM; INFANT; INFANT MORTALITY; INTELLIGENCE QUOTIENT; NERVE CELL DIFFERENTIATION; PERINATAL MORBIDITY; PREMATURITY; PRIORITY JOURNAL; REVIEW; RISK BENEFIT ANALYSIS; THYROID FUNCTION; VERY LOW BIRTH WEIGHT;

HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, VERY LOW BIRTH WEIGHT; THYROID DISEASES; THYROXINE;

EID: 0036063514     PISSN: 10408703     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008480-200208000-00017     Document Type: Review

References (42)

1. Thyroid function and thyroid hormone requirements of very preterm infants
2. Thyroid function in premature infants
3. Hypothyroxinemia in premature infants: Is thyroxine treatment necessary?
4. Thyroid function in the preterm infant
5. Ontogeny of iodothyronine deiodinases in human liver
6. Serum iodothyronines in the human fetus and the newborn: Evidence for an important role of placenta in fetal thyroid hormone homeostasis
7. 5′-mono-deiodinase activity in developing human cerebral cortex
8. Neurological damage to the fetus resulting from severe iodine deficiency during pregnancy
9. Timing of vulnerability of the brain to iodine deficiency in endemic cretinism
10. Early effects of iodine deficiency on radial glial cells of the hippocampus of the rat fetus: A model of neurologic cretinism
11. Congenital hypothyroidism, as studied in rats: Crucial role of maternal thyroxine but not of 3,5,3′ triiodothyronine in the protection of the fetal brain
12. The prenatal role of thyroid hormone evidenced by fetomaternal Pit-1 deficiency
13. Maternal-fetal transfer of thyroxine in congenital hypothyroidism due to a total organification defect of thyroid agenesis
14. Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child
15. Thyroid function in very preterm infants: Influences of gestational age and disease
16. Serum free thyroxine and free triiodothyronine concentrations in healthy fullterm, preterm and sick preterm neonates
17. Maturation of feedback control of thyrotropin in premature infants
18. Thyroid function in very low birth weight infants: Effects on neonatal hypothyroid screening
19. Topical iodine-containing antiseptics and subclinical hypothyroidism in preterm infants
20. Neonatal hypothyroxinemia: Effects of iodine intake and premature birth
21. Dopamine suppresses thyroid stimulating hormone secretion in neonatal hypothyroidism
22. Thyrotropin levels during hydrocortisone infusions that mimic festing-induced cortisol elevations: A clinical research center study
23. Serum free thyroxine concentration is not reduced in premature infants with respiratory distress syndrome
24. Mild impairment of neuro-otological function in early treated congenital hypothyroidism
25. Neonatal hypothyroidism: Treatment and outcome
26. Low serum thyroxine on initial newborn screening is essociated with intraventricular hemorrhage and death in very low birth weight infants
27. A longitudinal assessment of thyroid hormone concentrations in preterm infants younger than 30 weeks gestation during the first 2 weeks of life and their relation to outcome
28. Hypothyroxinemia of prematurity and infant neurodevelopment: A pilot study
29. The relation of transient hypothyroxinemia in preterm infants to neurologic development at two years of age
30. The relation between neonatal thyroxine levels and neurodevelopmental outcome at age 5 and 9 years in a national cohort of very preterm and/or very low birth weight infants
31. Low triiodothyronine concentration in preterm infants and subsequent intelligence quotient (IQ) at 8 year follow up
32. Reduction of mortality rate in premature infants by substitution of thyroid hormones
33. Results of controlled double-blind study of thyroid replacement in very low birth weight premature infants with hypothyroxinemia
34. Postnatal thyroxine administration for idiopethic respiratory distress syndrome in preterm infants
35. L-thyroxine treatment of preterm newborns: Clinical and endocrine effects
36. Postnatal thyroxine supplementation in infants less than 32 weeks gestation: Effects on pulmonary morbidity
37. Effects of thyroxine supplementation on neurologic development in infants born at less than 30 weeks gestation
38. Thyroid function in preterm new-borns: Is T4 treatment required in infants <27 weeks gestational age?
39. Thyroxine administration to infants of less than 30 weeks gestational age decreases plasma triiodothyronine concentrations
40. Thyroid function in very preterm newborns: Possible implications
41. Neonatal thyroxine supplementation in very preterm children: Developmental outcome evaluated at early school age
42. Australian collaborative trial of antenatal thyrotropin-releasing hormone: Adverse effects at 12-month follow-up